CTOR

Citius Oncology, Inc. is a biopharmaceutical company focused on developing and commercializing anti-cancer therapies. The company is headquartered in Cranford, New Jersey. Citius Oncology's pipeline includes novel treatments targeting solid tumors and hematological malignancies. The company emphasizes innovative drug formulations and combination therapies designed to improve patient outcomes in oncology.